Cart
sales@molnova.com
Kuwanon U
CAS No. 123702-95-4
Kuwanon U( —— )
Catalog No. M37866 CAS No. 123702-95-4
Kuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1359 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKuwanon U
-
NoteResearch use only, not for human use.
-
Brief DescriptionKuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively.
-
DescriptionKuwanon U is a strong cholinesterase inhibitor, exhibiting IC 50 values of 19.69 and 10.11 μM, and K i values of 6.48 and 9.59 μM for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively. Its potential application lies in Alzheimer's disease (AD) research .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123702-95-4
-
Formula Weight438.51
-
Molecular FormulaC26H30O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(O[C@@H](C1)C3=CC(C/C=C(/CCC=C(C)C)\C)=C(OC)C=C3O)=CC(O)=CC2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-Amino-5-Fluorophen...
It is an organic compunds with molecular fomula C6H6FNO.
-
Matairesinol
Matairesinol has radical and superoxide scavenging activities; it also has anti-angiogenic activity by suppressing mROS signaling , can decrease hypoxia-inducible factor-1α± in hypoxic HeLa cells.
-
Pentachloropseudilin
Pentachloropseudilin (PClP) is a reversible variant 1 myosin inhibitor with antimicrobial activity that inhibits Myo1s and class 5 myosins.
